| 2. Classification and Diagnosis of Diabetes: | Diabetes Care | 2020 | 1.2K |
| High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation | Obesity | 2020 | 1.1K |
| Diabetes is a risk factor for the progression and prognosis of COVID-19 | Diabetes/Metabolism Research and Reviews | 2020 | 721 |
| Psychosocial impact of COVID-19 | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 675 |
| The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system | Cytokine and Growth Factor Reviews | 2020 | 662 |
| 9. Pharmacologic Approaches to Glycemic Treatment: | Diabetes Care | 2020 | 573 |
| Development of therapeutic antibodies for the treatment of diseases | Journal of Biomedical Science | 2020 | 568 |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 515 |
| Artificial Intelligence (AI) applications for COVID-19 pandemic | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 511 |
| Impact of sex and gender on COVID-19 outcomes in Europe | Biology of Sex Differences | 2020 | 496 |
| 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetes Care | 2020 | 483 |
| Practical recommendations for the management of diabetes in patients with COVID-19 | Lancet Diabetes and Endocrinology,the | 2020 | 463 |
| SARS-CoV-2 infection: The role of cytokines in COVID-19 disease | Cytokine and Growth Factor Reviews | 2020 | 447 |
| Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - A systematic review, meta-analysis, and meta-regression | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 446 |
| Cardiovascular disease and COVID-19 | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 440 |
| Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York | Metabolism: Clinical and Experimental | 2020 | 437 |
| Effects of COVID-19 Lockdown on Lifestyle Behaviors in Children with Obesity Living in Verona, Italy: A Longitudinal Study | Obesity | 2020 | 437 |
| The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication | Frontiers in Endocrinology | 2020 | 428 |
| Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships | Obesity Reviews | 2020 | 427 |
| 6. Glycemic Targets: | Diabetes Care | 2020 | 417 |
| Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study | Lancet Diabetes and Endocrinology,the | 2020 | 407 |
| COVID-19 in people with diabetes: understanding the reasons for worse outcomes | Lancet Diabetes and Endocrinology,the | 2020 | 406 |
| COVID-19 pandemic, coronaviruses, and diabetes mellitus | American Journal of Physiology - Endocrinology and Metabolism | 2020 | 380 |
| Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study | Lancet Diabetes and Endocrinology,the | 2020 | 375 |
| COVID-19-Related School Closings and Risk of Weight Gain Among Children | Obesity | 2020 | 365 |
